Celon Pharma S.A. announced earnings results for the third quarter ended September 30, 2020. For the quarter, the company announced total revenue was PLN 30.456 million compared to PLN 23.998 million a year ago. Operating income was PLN 1.909 million compared to PLN 1.616 million a year ago. Net income was PLN 3.965 million compared to PLN 2.132 million a year ago. Basic earnings per share from continuing operations was PLN 0.23. For the nine months, total revenue was PLN 100.394 million compared to PLN 75.257 million a year ago. Operating income was PLN 23.727 million compared to PLN 8.047 million a year ago. Net income was PLN 24.722 million compared to PLN 10.293 million a year ago. Basic earnings per share from continuing operations was PLN 0.55.